Furthermore, NKG2D CAR-T cells from healthy donors or NSCLC patients’ peripheral blood induced tumor shrinkage, improved survival, increased body weight, increased tumor-infiltrating capacity, and elevated serum IFN-γ levels in mice. This evidence concerns the gene KLRK1 and neoplasm.